Joachim Kreuzburg - Sartorius Stedim Chairman of The Board and CEO
| SDMHF Stock | USD 207.75 12.25 5.57% |
Chairman
Dr. Joachim Kreuzburg has served as Chairman of the Board and Chief Executive Officer, Chairman of the Executive Committee of Sartorius Stedim Biotech SA since June 29, 2007. He is also Member of the Company Remuneration Committee. In addition to his duties at the Company, Dr. Kreuzburg held several other mandates, including Vice Chairman of the Supervisory Board of Sartorius Stedim Biotech GmbH and Member of the Board of Directors of Sartorius Mechatronics Japan K.K., among others. He started his career working as a Scientific Assistant at the Research Institute on Solar Energy of Lower Saxony from 1992 to 1995. Subsequently, he was Scientific Assistant at the department of Economics of Hannover University until 1999. He then joined Sartorius AG as Director of Finance and Investors Relations on May 1, 1999. In November 2002, he was appointed Member of the Management Board of Sartorius AG and Director of Finance, Administration and Investors Relations. Between May 2003 and November 2005, Dr. Kreuzburg served as Spokesperson of the Management Board of Sartorius AG. Since November 11, 2005, he was Chairman of the Management Board of Sartorius AG since 2007.
| Age | 58 |
| Tenure | 17 years |
| Professional Marks | Ph.D |
| Phone | 33 4 42 84 56 00 |
| Web | https://www.sartorius.com |
Sartorius Stedim Management Efficiency
The company has return on total asset (ROA) of 0.1389 % which means that it generated a profit of $0.1389 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3306 %, meaning that it generated $0.3306 on every $100 dollars invested by stockholders. Sartorius Stedim's management efficiency ratios could be used to measure how well Sartorius Stedim manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Vincent Forlenza | Becton Dickinson and | 66 | |
| Peter Farrell | ResMed Inc | 78 | |
| Allan Rubenstein | The Cooper Companies | 74 | |
| Fred Lampropoulos | Merit Medical Systems | 74 | |
| Mark Logan | STAAR Surgical | 75 | |
| Vivek Jain | ICU Medical | 52 | |
| Patrick Zenner | West Pharmaceutical Services | 73 | |
| Stephen MacMillan | Hologic | 60 | |
| Thomas Polen | Becton Dickinson and | 51 | |
| Caren Mason | STAAR Surgical | 70 | |
| Liam Kelly | Teleflex Incorporated | 57 | |
| Alexander Rich | Repligen | 86 | |
| Jay Stein | Hologic | 72 | |
| Benson Smith | Teleflex Incorporated | 71 | |
| Thomas Bender | The Cooper Companies | 78 | |
Management Performance
| Return On Equity | 0.33 | |||
| Return On Asset | 0.14 |
Sartorius Stedim Biotech Leadership Team
Elected by the shareholders, the Sartorius Stedim's board of directors comprises two types of representatives: Sartorius Stedim inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Stedim's management team and ensure that shareholders' interests are well served. Sartorius Stedim's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Stedim's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andreas Theisen, Director of Investor Relations | ||
| Reinhard Vogt, Executive VP of Marketing Sales and Services and Director | ||
| AnneMarie Graffin, Non-Executive Independent Director | ||
| Petra Kirchhoff, Vice President of Corporate Communications and Investor Relations | ||
| Henri Riey, Non-Executive Independent Director | ||
| Michael Melingo, Deputy CEO - Marketing, Services and Business Development | ||
| OscarWerner Reif, Deputy CEO - Research and Development, Member of the Executive Committee and Executive Director | ||
| Olivier Guitard, Head BPS | ||
| Joachim Kreuzburg, Chairman of The Board and CEO | ||
| Volker Niebel, Executive VP of Operations and IT and Director | ||
| Bernard Lemaitre, Non-Executive Director | ||
| Susan Dexter, Non-Executive Independent Director | ||
| Heiko Imhl, VP Relations | ||
| Arnold Picot, Chairman of Supervisory Board, Member of The Admin. Board, Non Executive Director, Chairman of Remuneration Committee and Member of Audit Committee | ||
| Lothar Kappich, Director | ||
| Joerg Pfirrmann, Member of the Executive Committee - Finance, Information Technology, Human Resources | ||
| Benedikt Orzelek, Investor Relations Contact | ||
| John Mackay, Sales Marketing | ||
| Liliane Lassus, Non-Executive Director |
Sartorius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Stedim a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.33 | |||
| Return On Asset | 0.14 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 32.97 B | |||
| Shares Outstanding | 92.17 M | |||
| Shares Owned By Insiders | 73.81 % | |||
| Shares Owned By Institutions | 13.73 % | |||
| Price To Earning | 60.34 X | |||
| Price To Book | 13.58 X |
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Sartorius Stedim Biotech information on this page should be used as a complementary analysis to other Sartorius Stedim's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |